Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Y Y Ooi

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Advances in Experimental Medicine and Biology|April 15, 2020
Translational Potential of Non-coding RNAs for Cardiovascular DiseaseJenny Y Y Ooi, Bianca C Bernardo
Future Medicinal Chemistry|January 29, 2014
The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophyJenny Y Y Ooi, Bianca C Bernardo, Julie R McMullen
Archives of Toxicology|March 16, 2020
Clusterin is regulated by IGF1-PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicitySebastian Bass-Stringer, Jenny Y Y Ooi, Julie R McMullen
STAR Protocols|October 25, 2025
Protocol for in vitro immunofluorescence staining in a Transwell co-culture systemJenny Y Y Ooi, Yung Shing Tsang, Lawrence P McMahon, et al.
Bioscience Reports|November 13, 2010
A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processingSteven W Long, Jenny Y Y Ooi, Peter M Yau, et al.
Future Medicinal Chemistry|September 25, 2015
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heartBianca C Bernardo, Jenny Y Y Ooi, Ruby C Y Lin, et al.
Physiological Reviews|January 20, 2018
Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging ConceptsBianca C Bernardo, Jenny Y Y Ooi, Kate L Weeks, et al.
Advances in Experimental Medicine and Biology|November 4, 2017
The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and ProtectionKate L Weeks, Bianca C Bernardo, Jenny Y Y Ooi, et al.
Archives of Toxicology|February 25, 2015
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targetsYow Keat Tham, Bianca C Bernardo, Jenny Y Y Ooi, et al.
RNA Biology|April 29, 2016
Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseasesJenny Y Y Ooi, Bianca C Bernardo, Saloni Singla, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Advances in Experimental Medicine and Biology|April 15, 2020
Translational Potential of Non-coding RNAs for Cardiovascular DiseaseJenny Y Y Ooi, Bianca C Bernardo
Future Medicinal Chemistry|January 29, 2014
The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophyJenny Y Y Ooi, Bianca C Bernardo, Julie R McMullen
Archives of Toxicology|March 16, 2020
Clusterin is regulated by IGF1-PI3K signaling in the heart: implications for biomarker and drug target discovery, and cardiotoxicitySebastian Bass-Stringer, Jenny Y Y Ooi, Julie R McMullen
STAR Protocols|October 25, 2025
Protocol for in vitro immunofluorescence staining in a Transwell co-culture systemJenny Y Y Ooi, Yung Shing Tsang, Lawrence P McMahon, et al.
Bioscience Reports|November 13, 2010
A brain-derived MeCP2 complex supports a role for MeCP2 in RNA processingSteven W Long, Jenny Y Y Ooi, Peter M Yau, et al.
Future Medicinal Chemistry|September 25, 2015
miRNA therapeutics: a new class of drugs with potential therapeutic applications in the heartBianca C Bernardo, Jenny Y Y Ooi, Ruby C Y Lin, et al.
Physiological Reviews|January 20, 2018
Understanding Key Mechanisms of Exercise-Induced Cardiac Protection to Mitigate Disease: Current Knowledge and Emerging ConceptsBianca C Bernardo, Jenny Y Y Ooi, Kate L Weeks, et al.
Advances in Experimental Medicine and Biology|November 4, 2017
The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and ProtectionKate L Weeks, Bianca C Bernardo, Jenny Y Y Ooi, et al.
Archives of Toxicology|February 25, 2015
Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targetsYow Keat Tham, Bianca C Bernardo, Jenny Y Y Ooi, et al.
RNA Biology|April 29, 2016
Identification of miR-34 regulatory networks in settings of disease and antimiR-therapy: Implications for treating cardiac pathology and other diseasesJenny Y Y Ooi, Bianca C Bernardo, Saloni Singla, et al.
Pageof 3